Identifying a protein panel for early cancer detection for women at high risk for breast cancer; first results from the multicenter TESTBREAST study

      Background: Women at high risk of developing breast cancer due to mutations in susceptibility genes or a familial predisposition undergo adapted screening programs. However, the timing of screening is still an issue, amongst others due to the occurrence of interval cancers and because imaging is not possible during pregnancy and lactation. Therefore, the multicenter, longitudinal, prospective TESTBREAST study aims to identify a novel panel of blood-based protein biomarkers that enables early detection of breast cancer for high-risk women using liquid biopsies, to improve the current screening program.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect